Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).
| Image |  |
|---|---|
| Description | scientific article published on 24 October 2017 |
| Author/s |
author: Janet Pope |
| Publication date | October 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |